Ships: 1-2 business days
Product Specific References for Applications and Species
Immunocytochemistry: Mouse | ||
PMID | Dilution | Publication |
26758690 | 1:200 | Belluzzi, E., et al. 2016. LRRK2 phosphorylates pre-synaptic N-ethylmaleimide sensitive fusion (NSF) protein enhancing its ATPase activity and SNARE complex disassembling rate.. Molecular Degeneration, 1. |
26365310 | 1:50 | Choi, I., et al. 2015. LRRK2 G2019S mutation attenuates microglial motility by inhibiting focal adhesion kinase.. Nature Communications, 8255. |
Immunohistochemistry: Mouse | ||
PMID | Dilution | Publication |
23560750 | 1:1000 | Davies, P., et al. 2013. Comprehensive characterization and optimization of anti-LRRK2 (leucine-rich repeat kinase 2) monoclonal antibodies.. Biochemical Journal, 101-13. |
Immunohistochemistry: Rat | ||
PMID | Dilution | Publication |
24927544 | not listed | Daher, J.P., et al. 2014. Abrogation of α-synuclein-mediated dopaminergic neurodegeneration in LRRK2-deficient rats.. PNAS USA, 9289-9294. |
Western Blot: Mouse | ||
PMID | Dilution | Publication |
23560750 | 1:1000 | Davies, P., et al. 2013. Comprehensive characterization and optimization of anti-LRRK2 (leucine-rich repeat kinase 2) monoclonal antibodies.. Biochemical Journal, 101-13. |
24427314 | not listed | Dorval, V., et al. 2014. Gene and MicroRNA transcriptome analysis of Parkinson''s related LRRK2 mouse models.. PLoS One, e85510. |